Searched for
DRUG RECALL MECHANISMS
“Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- 'Drug companies in upgrade mode need more time for GMP compliance': IDMAA pharma group is requesting more time for manufacturers to meet new quality standards. Many companies have started upgrades but face genui...
- Cough syrup deaths: IMA demands Nadda's intervention, withdrawal of case against pediatricianThe Indian Medical Association (IMA) has urged the Union Health Minister to intervene and withdraw the case against a pediatrician arrested...
- Pharma companies may lose licence if drugs fail testsThe health ministry is considering strict actions, including immediate license suspensions, for drugmakers producing substandard drugs. Thi...
- Govt revamps pharma scheme; broadens eligibility criteria, brings in flexible financing optionsThe Indian government has revamped the Pharmaceuticals Technology Upgradation Assistance Scheme (PTUAS) to support drug companies in upgrad...
- Health ministry to organise 'Chintan Shivir' to explore ways to build trust on Indian drugs"The aim is to build trust and confidence on the quality of Indian drugs, cosmetics and medical devices in the domestic and global markets."
- India needs a national drug recall law without further delay. Here's whyThe syrup was found by WHO to be adulterated with diethylene glycol (DEG) and ethylene glycol. Such adulteration is not uncommon in India. ...
- India, Russia require joint efforts to address multiple security challenges in Afghanistan: Envoy to MoscowIndia & Russia are particularly affected by these developments. This situation poses threat to the interests of both India & Russia on acco...
- Union Health Ministry notifies medical equipment used on humans or animals as "drugs""In pursuance of sub-clause (iv) of clause (b) of section 3 of the Drugs and Cosmetics Act, 1940, the Central Government, after consultatio...
- Govt issues draft notification to bring all medical devices under single regulatory frameworkThe union health ministry has come out with the draft notification, making it mandatory for all the devices to get certified by the Central...
- Pharma companies can’t sell tweaked drugs under old brand nameThe issue has been discussed for years now, and was deliberated in several Drugs Consultative Committee meetings held since 2008.
- Interim relief: J&J told to pay Rs 20 lakh to each recipient of faulty hip implantAll patients who got the implants will be evaluated individually to gauge the extent of medical problems arising from the bad implants and ...
- Govt seeks complaints on ‘dissolving stents’, but has no system to act on itThe Indian Pharmacopoeia Commission in Ghaziabad is the national coordination centre for the materio vigilance programme.
- Panel prescribes national portal to keep an eye on online pharmaciesThe 121-page report will now be studied by the ministry and suitable changes in the legislative provisions may be considered to allow onlin...
- Ranbaxy whistle blower Dinesh Thakur suggests strict prosecution laws to fix drug industryDinesh Thakur says the country needs strict criminal prosecution against suppliers of substandard drugs, a nationwide product recall system.
- India needs strict prosecution laws to fix drug regulatory system: Ranbaxy whistleblower Dinesh ThakurIn his report, Thakur suggested greater empowerment for the central administration by amending certain legal provisions like Drugs and Cosm...
- IIT Madras sets target to kill only cancer cellsThe team has created a class of molecules called immunotoxins to specifically target cancer cells, while leaving healthy cells unaffected.
- Indian pharma companies should shed jugaad attitude: G V Prasad, CEO (Dr Reddy’s Laboratories)We are investing in innovations, trying to work on products focussed at unmet medical needs and biosimilars are somewhere in between, says ...
- Drug watchdog’s Quixotic dallianceRam Vilas Paswan’s indignant remarks on the huge trade margins in the pharma sector, especially in the unbranded drugs’ category and threat...
Load More
